Drugmaker Astellas Has Claims For DOJ Settlement Coverage

By Elizabeth Daley · November 29, 2022, 6:38 PM EST

Pharmaceutical company Astellas' settlement with the U.S. Department of Justice for more than $102 million over its alleged Medicare fraud scheme involving medication for castration-resistant prostate cancer may be covered by...

To view the full article, register now.